By Benjamin Chiou
Date: Wednesday 04 Nov 2026
(Sharecast News) - Medical technology group Smith & Nephew cut its full-year revenue and profit forecasts on Wednesday as weakness in its US hip and knee implant businesses continued to weigh on performance, despite an acceleration in third-quarter sales growth.
The FTSE 100 company now expects underlying revenue growth of around...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news